Breaking News Instant updates and real-time market news.

ADMS

Adamas Pharmaceuticals

$7.30 /

+0.64 (+9.61%)

09:08
12/17/19
12/17
09:08
12/17/19
09:08

Adamas Pharmaceuticals says INROADS Phase 3 trial achieves primary endpoint

Adamas Pharmaceuticals announced that INROADS, a 3-arm, randomized, double-blind, placebo-controlled study in 594 multiple sclerosis patients with walking impairment met its primary endpoint. Results from the study showed that patients taking 274 mg ADS-5102 had a statistically significant improvement in response rate of 21.1% compared to 11.3% taking placebo. Response was defined as at least a 20% improvement in walking speed from baseline to 12 weeks post-treatment, as measured by the Timed 25 Foot Walk. Additionally, the response rate for patients taking a lower dose of 137 mg ADS-5102 was 17.6%. ADS-5102 did not demonstrate a significant effect on the secondary walking measures at either dose. The most common adverse events were: peripheral edema, dry mouth, fall, constipation, UTI, and insomnia. 20.5% of patients discontinued study drug due to adverse events in the 274 mg group, compared to 6.4% in the 137 mg group, and 3.8% in the placebo group. The reported adverse events associated with ADS-5102 in this study were dose-dependent and consistent with the known safety profile of amantadine.

ADMS Adamas Pharmaceuticals
$7.30 /

+0.64 (+9.61%)

09/09/19
Fly Intel: Top five analyst initiations
09/30/19 BOFA
Adamas Pharmaceuticals downgraded to Underperform from Neutral at BofA/Merrill
09/30/19 BOFA
Adamas Pharmaceuticals downgraded to Underperform from Neutral at BofA/Merrill
11/08/19 JMPS
Adamas Pharmaceuticals price target lowered to $16 from $57 at JMP Securities

TODAY'S FREE FLY STORIES

Recommendations
Tesla resumed with Sell rating at UBS, price target rises to $410 from $160 » 07:19
01/23/20
01/23
07:19
01/23/20
07:19
TSLA

Tesla

$569.49 /

+22.06 (+4.03%)

UBS analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Wearables, Services growth should highlight solid Q1 for Apple, says KeyBanc » 07:19
01/23/20
01/23
07:19
01/23/20
07:19
AAPL

Apple

$317.85 /

+1.46 (+0.46%)

KeyBanc analyst Andy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sandy Spring Bancorp reports Q4 EPS 80c, two est. 79c » 07:17
01/23/20
01/23
07:17
01/23/20
07:17
SASR

Sandy Spring Bancorp

$36.10 /

-0.17 (-0.47%)

"We delivered a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
FuelCell downgraded to Sell from Hold at Craig-Hallum » 07:17
01/23/20
01/23
07:17
01/23/20
07:17
FCEL

FuelCell

$2.22 /

-0.655 (-22.82%)

Craig-Hallum analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Franklin Financial Network downgraded to Market Perform from Outperform at Raymond James » 07:14
01/23/20
01/23
07:14
01/23/20
07:14
FSB

Franklin Financial Network

$38.50 /

+4.38 (+12.84%)

Raymond James downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Strata receives 510(k) clearance for XTRAC Momentum 308nm Excimer Laser System » 07:14
01/23/20
01/23
07:14
01/23/20
07:14
SSKN

Strata Skin Sciences

$2.03 /

-0.05 (-2.40%)

STRATA Skin Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Avery Dennison price target raised to $129 from $117 at Credit Suisse » 07:13
01/23/20
01/23
07:13
01/23/20
07:13
AVY

Avery Dennison

$130.21 /

-0.35 (-0.27%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cubic CTS division partners with Paragon Vitamins for advertising platform » 07:12
01/23/20
01/23
07:12
01/23/20
07:12
CUB

Cubic

$68.01 /

-0.57 (-0.83%)

Cubic announced its Cubic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Evolent Health price target raised to $16 from $10 at Cantor Fitzgerald » 07:12
01/23/20
01/23
07:12
01/23/20
07:12
EVH

Evolent Health

$10.87 /

-0.06 (-0.55%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Summit Therapeutics says BARDA expands ridinilazole award by $8.8M » 07:11
01/23/20
01/23
07:11
01/23/20
07:11
SMMT

Summit Therapeutics

$1.56 /

+0.11 (+7.59%)

Summit Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
JetBlue CEO says 'confident' in ability to deliver 2020 EPS goals » 07:11
01/23/20
01/23
07:11
01/23/20
07:11
JBLU

JetBlue

$19.80 /

+0.71 (+3.72%)

Robin Hayes,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Incyte price target raised to $83 from $65 at Cantor Fitzgerald » 07:10
01/23/20
01/23
07:10
01/23/20
07:10
INCY

Incyte

$78.47 /

-0.22 (-0.28%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Applied Genetic reports six-month data from Phase 1/2 trials in achromatopsia » 07:10
01/23/20
01/23
07:10
01/23/20
07:10
AGTC

Applied Genetic

$9.86 /

+1.605 (+19.44%)

Applied Genetic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Texas Instruments price target raised to $130 from $125 at Stifel » 07:10
01/23/20
01/23
07:10
01/23/20
07:10
TXN

Texas Instruments

$133.38 /

+2.53 (+1.93%)

Stifel analyst Tore…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Comcast reports NBCUniversal Q4 revenue down 2.6% to $9.2B » 07:10
01/23/20
01/23
07:10
01/23/20
07:10
CMCSA

Comcast

$47.50 /

+0.19 (+0.40%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

Revenue for NBCUniversal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Comcast reports Q4 Cable Communications revenue up 2.6% to $14.8B » 07:09
01/23/20
01/23
07:09
01/23/20
07:09
CMCSA

Comcast

$47.50 /

+0.19 (+0.40%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

Revenue for Cable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Moody's to acquire Regulatory DataCorp for $700M » 07:09
01/23/20
01/23
07:09
01/23/20
07:09
MCO

Moody's

$257.50 /

+1.16 (+0.45%)

Moody's announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Procter & Gamble down 3.2% after reporting Q2 results  07:08
01/23/20
01/23
07:08
01/23/20
07:08
PG

Procter & Gamble

$125.56 /

+0.2 (+0.16%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Comcast reports Q4 adjusted EPS 79c, consensus 76c » 07:08
01/23/20
01/23
07:08
01/23/20
07:08
CMCSA

Comcast

$47.50 /

+0.19 (+0.40%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Dermira downgraded to Neutral from Buy at H.C. Wainwright » 07:08
01/23/20
01/23
07:08
01/23/20
07:08
DERM

Dermira

$18.84 /

-0.31 (-1.62%)

, LLY

Eli Lilly

$141.59 /

+0.69 (+0.49%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Procter & Gamble narrows FY20 revenue growth guidance to 4%-5% from 3%-5% » 07:08
01/23/20
01/23
07:08
01/23/20
07:08
PG

Procter & Gamble

$125.56 /

+0.2 (+0.16%)

Procter & Gamble…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Altimmune announces results for ALT-702 in preclinical model » 07:07
01/23/20
01/23
07:07
01/23/20
07:07
ALT

Altimmune

$2.02 /

-0.01 (-0.49%)

Altimmune announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Comcast increases dividend 10% to 92c per share on an annualized basis » 07:07
01/23/20
01/23
07:07
01/23/20
07:07
CMCSA

Comcast

$47.50 /

+0.19 (+0.40%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

Comcast said that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Corbus Pharmaceuticals management to meet with RBC Capital » 07:06
01/23/20
01/23
07:06
01/23/20
07:06
CRBP

Corbus Pharmaceuticals

$7.22 /

+0.075 (+1.05%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
JetBlue sees Q1 EPS 10c-20c, consensus 19c » 07:06
01/23/20
01/23
07:06
01/23/20
07:06
JBLU

JetBlue

$19.80 /

+0.71 (+3.72%)

Capacity is expected to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.